Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute intraocular inflammation following intravitreal injection of bevacizumab--a large cluster of cases.

× No keyword cloud information.

8 in total

1. Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery.

Authors: Brennan D Eadie; Mahyar Etminan; Bruce C Carleton; David A Maberley; Frederick S Mikelberg
Journal: JAMA Ophthalmol Date: 2017-04-01 Impact factor: 7.389

2. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.

Authors: Roger A Goldberg; Harry W Flynn; Darlene Miller; Serafin Gonzalez; Ryan F Isom
Journal: Ophthalmology Date: 2013-02-28 Impact factor: 12.079

3. A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.

Authors: Morteza Entezari; Saeed Karimi; Hamid Ahmadieh; Amir Hossein Mahmoudi; Hamid Parhizgar; Mehdi Yaseri
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2016-07-04 Impact factor: 3.117

Review 4. Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis.

Authors: Douglas K Sigford; Shivani Reddy; Christine Mollineaux; Shlomit Schaal
Journal: Clin Ophthalmol Date: 2015-05-02

Acute intraocular inflammation following intravitreal injection of bevacizumab--a large cluster of cases.

1. Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery.

2. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.

3. A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.

Review 4. Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis.

5. Intravitreal bevacizumab.

6. Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis.

7. Acute sterile endophthalmitis following intravitreal bevacizumab: case series.

Review 8. Postoperative Endophthalmitis and Toxic Anterior Segment Syndrome Prophylaxis: 2020 Update.